Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cannabis SuisseCSUI -42.35% Debt-to-EBITDA is 11.44 as of Feb. 2026. The stock has 2 warning signs investors should review. Among 1,274 Real Estate companies, Cannabis Suisse ranks worse than 75.51% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Cannabis Suisse's Debt-to-EBITDA or its related term are showing as below:
CSUI'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -6.05 Med: -1.11 Max: 11.37
Current: 11.37
During the past 10 years, the highest Debt-to-EBITDA Ratio of Cannabis Suisse was 11.37. The lowest was -6.05. And the median was -1.11.
CSUI's Debt-to-EBITDA is ranked worse than 75.51% of 1274
companies
in the Real Estate industry
Industry Median: 5.64
vs CSUI: 11.37
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Cannabis Suisse Debt-to-EBITDA Related Terms
Cannabis Suisse Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Cannabis Suisse's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CSUI vs GMPW, AOXY, HBUV: Debt-to-EBITDA Comparison
For the Real Estate Services subindustry, Cannabis Suisse's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabis Suisse Debt-to-EBITDA vs Real Estate Industry
For the Real Estate industry and Real Estate sector, Cannabis Suisse's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Cannabis Suisse's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Feb. 2026) EBITDA data.
Cannabis Suisse (CSUI) has a Debt-to-EBITDA of 11.44 as of Feb. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Cannabis Suisse. According to the industry distribution chart, Cannabis Suisse ranks #962 out of 1274 companies in the Real Estate industry, placing it in the top 75.5%.
Is Cannabis Suisse's Debt-to-EBITDA too high?
Cannabis Suisse's current Debt-to-EBITDA is 11.44. The Real Estate industry median Debt-to-EBITDA is 5.64. Cannabis Suisse's value of 11.44 is 102.8% above this industry median. Based on the distribution chart, Cannabis Suisse ranks #962 out of 1274 companies in the Real Estate industry, which is in the bottom quartile relative to peers.
How does Cannabis Suisse's Debt-to-EBITDA compare to GMPW and AOXY?
According to the Real Estate industry distribution chart, Cannabis Suisse ranks #962 out of 1274 companies for Debt-to-EBITDA. This places Cannabis Suisse in the lower half of its industry. The industry median Debt-to-EBITDA is 5.64. Cannabis Suisse's value of 11.44 is 102.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Real Estate company?
The median Debt-to-EBITDA among Real Estate companies is 5.64, based on 1,274 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cannabis Suisse's current Debt-to-EBITDA of 11.44 is 102.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Cannabis Suisse. For the Real Estate industry, the median Debt-to-EBITDA is 5.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabis Suisse's current Debt-to-EBITDA is 11.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Suisse stock overvalued right now?
Cannabis Suisse (CSUI) has a current Debt-to-EBITDA of 11.44. The current Debt-to-EBITDA is 11.44 and 102.8% above the Real Estate industry median of 5.64. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Cannabis Suisse (CSUI), the current Debt-to-EBITDA is 11.44 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannabis Suisse Corp is engaged in the rental of commercial office and industrial space. The company currently subleases a portion of a commercial building to a third party. its operations focus on providing flexible and efficient space solutions within the commercial real estate market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSUI has been successfully added to your 
